topline
Areteia Therapeutics Posts Phase 3 Win for Oral Asthma Drug Dexpramipexole
Areteia Therapeutics; dexpramipexole; Phase 3; oral asthma therapy; biologic blockbusters; eosinophilic asthma; EXHALE-4; topline results
Bicycle Therapeutics Faces Stock Decline After Releasing Topline Data and Post-Hoc Analyses
Bicycle Therapeutics, stock decline, topline data, post-hoc analyses, cancer trials, zelenectide pevedotin, BT5528, metastatic urothelial cancer, Nectin-4 gene amplification.